2 October 2013
Immunocore has won the Best Biotech Dealmaker Award of 2013 at the OBN (Oxfordshire Bioscience Network) annual awards. The prestigious industry award recognizes Immunocore’s achievements in closing two major partnership agreements this summer with Genentech, a member of Roche Group, and GlaxoSmithKline to discover, develop and commercialise ImmTAC therapies against multiple targets.
Please click on the link below to download the full Press Release:
